NIR-II Probes for Deep-Tissue Imaging

• NIR-II probes are optical emitters that operate in the 1000–1400 nm range, reducing tissue scattering for deep, high-resolution imaging.
• They are formulated with biocompatible coatings like DSPE-mPEG and PLPEG5000 to enhance stability, circulation, and minimize cytotoxicity.
• Engineered defects and optimized excitation/emission provide high photostability and brightness, ideal for non-invasive vascular mapping and quantum sensing.

Near-infrared-II (NIR-II) probes are optical emitters that operate within the spectral range of approximately 1000–1400 nm (commonly designated as the second biological window or NIR-II window). These fluorophores are engineered to leverage reduced tissue scattering and minimized endogenous autofluorescence in biological specimens, facilitating deep-tissue, high-resolution imaging. Representative NIR-II probes include single-walled carbon nanotubes (SWNTs), ultrashort carbon nanotubes with luminescent color centers, and quantum-emitting color centers in diamond. Their distinct photophysical properties, surface chemistry, and imaging performance are actively being developed and benchmarked for biomedical research, photonics, and quantum applications (Welsher et al., 2011, Hong et al., 2012, Nandi et al., 14 Jan 2025, Johnson et al., 2024).

1. Physical Basis and Spectral Properties

NIR-II probes are defined by their emission in the range 1000–1400 nm, which yields optimal optical penetration because the reduced scattering coefficient in tissue, $\mu_s'(\lambda) \propto \lambda^{-w}$, decreases with increasing wavelength ($w \approx 0.22$–$2.4$ depending on tissue composition) (Welsher et al., 2011, Hong et al., 2012). Water absorption increases slightly in NIR-II (e.g., $\mu_a,\mathrm{water} \approx 0.098$ mm$^{-1}$ at 800 nm and $\approx 0.14$ mm$^{-1}$ at 1300 nm), but the overall effect is maximization of the effective penetration depth $\delta$, as given by the diffusion model:

$$\delta = \left[3 \mu_a (\mu_a + \mu_s') \right]^{-1/2}$$

Excitation is typically performed between 785–808 nm using diode lasers or filtered lamps, while emission is collected with long-pass filters (e.g., 900 nm, 1100 nm) and detected by InGaAs cameras sensitive to 1.1–1.7 μm (Welsher et al., 2011, Hong et al., 2012). SWNTs and related probes exhibit multiple emission peaks spanning 1000–1400 nm, with intensity maxima set by their microstructure or (n,m) chirality (SWNTs: $\sim1130$–$1320$ nm; ultrashort CNT color centers, E$_{11}^*$: $1108$–$1140$ nm; diamond $N_2V^-$ ZPL: $986$ nm, vibronic sideband: $1120$ nm) (Nandi et al., 14 Jan 2025, Johnson et al., 2024).

2. Probe Formulation, Functionalization, and Biocompatibility

The colloidal and biological properties of NIR-II probes are highly dependent on their functionalization strategies:

• SWNT-based probes: Preparation from HiPCO or CoMoCAT SWNTs involves surfactant-assisted dispersion (e.g., sodium cholate, sodium deoxycholate), ultracentrifugation to remove bundles, and exchange into DSPE-mPEG (methoxy-polyethylene glycol-phospholipid, MW ~5,000), which imparts colloidal stability, resistance to protein adsorption, prolonged circulation ($t_{1/2} \approx 5$ h), and minimal cytotoxicity (Welsher et al., 2011, Hong et al., 2012).
• IRDye-800–conjugated SWNTs: Covalent coupling of IRDye-800 NHS ester to PEG–NH$_2$-coated SWNTs yields hybrid probes with emission in both NIR-I (ICG, $800$ nm) and NIR-II (SWNT backbone $1.1$–$1.4$ μm); the conjugation reduces dye quantum yield by up to 60% due to quenching but ensures water solubility and biocompatibility (Hong et al., 2012).
• Ultrashort carbon nanotubes with luminescent color centers (uCCNTs): Synthesis routes include (A) sidewall aryl functionalization followed by oxidative cutting, and (B) tip-sonication of monodisperse SWNTs followed by oxygen-defect implantation. Surface passivation is achieved via surfactant-exchange into phospholipid–PEG (PLPEG5000), essential for imaging in physiological media (Nandi et al., 14 Jan 2025).
• Detonation nanodiamond (DND) color centers ($N_2V^-$): Formation relies on nitrogen doping and vacancy generation (HPHT or CVD diamond), with air oxidation facilitating stable NIR-II PL on nanoparticle surfaces. PLPEG-type coatings are similarly employed for biocompatibility and cellular uptake (Johnson et al., 2024).

3. Photophysical Mechanisms and Quantum Yield

Photon absorption and emission in NIR-II agents are dictated by their characteristic electronic structure and defect-induced trap states:

• SWNTs: Quantum yield (Φ) in biocompatible DSPE-mPEG suspension is low, typically $Φ \approx 10^{-3}$–$10^{-2}$, but surfactant-exchange and defect engineering can raise single-particle Φ to $2.5\%$–$12\%$ (oxygen-defect ultrashorts) (Nandi et al., 14 Jan 2025, Hong et al., 2012). Emission arises from exciton recombination at localized trap states (color centers), shifting the PL maximum into deep NIR-II.
• DND $N_2V^-$ centers: N₂V⁻ exhibits a broad NIR-II emission band (950–1400 nm), with a zero-phonon line at $986.5 \pm 0.5$ nm (room temperature linewidth $10$–$11$ nm in nanoparticles), and vibronic sideband peaking near $1120$ nm (Johnson et al., 2024). PL lifetime is $\tau = 0.323 \pm 0.002$ ns, corresponding to a spontaneous emission rate $\gamma = 1/\tau \approx 3.1 \times 10^9$ s$^{-1}$.
• Brightness metric: Photon count rates for NIR-II probes span a wide range depending on formulation and imaging conditions. DNDs with N₂V⁻ can yield $\sim 30$ kcps per aggregate in cells, with SWNTs emitting $\sim 10$–$100$ kcps and quantum dots (PbS/CdHgTe) up to $10^6$ cps (Johnson et al., 2024). Single ultrashort CNTs achieve $\sim 12\%$ quantum yield and brightness of $3.8 \times 10^6$ M$^{-1} \cdot$cm$^{-1}$ (Nandi et al., 14 Jan 2025).

4. Imaging System Performance and Dynamic Contrast

NIR-II imaging exploits reduced tissue scattering and enhanced contrast, implemented via advanced camera systems and dynamic analysis:

Imaging Modality	Spatial Resolution	Temporal Resolution	Penetration Depth
NIR-II probe (SWNT/uCNT)	Down to $30~\mu$m	$<200$ ms/frame	$1$–$3$ mm (up to $5$ mm)
NIR-I dye (ICG, QDs)	$>$100~$\mu$m	(comparable)	$<$1 mm
micro-CT/MRI	$\gtrsim 40~\mu$m$^\ast$	$2$ h scan / seconds per slice	Whole body, low contrast
Ultrasound (Doppler)	Limited at depth	up to $1$ kHz	Several cm, lower SBR

$^\ast$Micro-CT's effective resolvable vessel diameters are $\geq 100~\mu$m (Hong et al., 2012).

• Real-time anatomical imaging (e.g., mouse organs during SWNT injection) is accomplished with video rates $>14$ fps (SWNTs: $50$ ms exposure, $19$ ms readout) (Welsher et al., 2011).
• Principal Component Analysis (PCA) is used to enhance dynamic contrast; PCA decomposition of the pixel-time intensity matrix $X$ allows separation of organs and vessel phases based on blood-flow kinetics (Welsher et al., 2011, Hong et al., 2012). Individual organs are mapped to distinct principal components and color-coded for visualization.
• Quantitative blood-flow velocity extraction employs both flow-front tracking ($v = \Delta x / \Delta t$) and intensity-rise analysis ($v = k \cdot dI/dt$, calibrated coefficient $k$) for absolute measurement of vascular hemodynamics, spanning velocities from $0.16$ cm/s (ischemic) to $5$ cm/s (healthy) (Hong et al., 2012).

5. Comparative Evaluation and Emerging Probes

NIR-II imaging demonstrates several advantages over established modalities and is expanding beyond SWNTs to new materials:

• Feature Fidelity and Depth: SWNT-based probes exhibit reduced feature broadening at increased depth compared to NIR-I dyes, yielding higher anatomical resolution through several millimeters of tissue (Welsher et al., 2011, Hong et al., 2012).
• Photostability: DND color centers ($N_2V^-$) and ultrashort color-center CNTs show minimal blinking and photobleaching, supporting long-duration single-particle and aggregate imaging (Johnson et al., 2024, Nandi et al., 14 Jan 2025).
• Biological Compatibility: PEGylation and related stealth surface coatings (DSPE-mPEG, PLPEG5000) are essential for stability and reduced toxicity, preserving quantum yield and circulation time (Welsher et al., 2011, Hong et al., 2012, Nandi et al., 14 Jan 2025).
• Practical Applications: NIR-II imaging is deployed for non-invasive vascular mapping, dynamic contrast angiogenesis studies, deep organ functional imaging, pre-clinical diagnostics, image-guided surgery, and high-speed single-particle tracking in thick tissue (Welsher et al., 2011, Hong et al., 2012, Nandi et al., 14 Jan 2025, Johnson et al., 2024).
• Telecom and Quantum Integration: N₂V⁻ emission overlaps the fiber-optic O-band (1260–1360 nm), suggesting direct compatibility for on-chip photonic platforms and quantum sensing (Johnson et al., 2024).

6. Practical Design Guidelines and Future Directions

Development of NIR-II probes is guided by optimization strategies tailored to application and imaging demands:

• Defect Chemistry: Oxygen defects via Fenton-like reaction yield the highest single-tube quantum yields (up to $12\%$, (Nandi et al., 14 Jan 2025)).
• Defect Density: Control of trap density ($\sim4$–$8$ defects/$\mu$m) maximizes brightness by balancing radiative recombination against non-radiative quenching (Nandi et al., 14 Jan 2025).
• Quenching Minimization: Over-sonication, aggressive oxidation, and uncontrolled functionalization increase quenchers and diminish brightness—protocol selection is essential (Nandi et al., 14 Jan 2025).
• Surface Coating: Exchange into PLPEG (or DSPE-mPEG for SWNTs) is mandatory for bioimaging; stability is confirmed by PL peak shifts and colloidal behavior (Welsher et al., 2011, Hong et al., 2012, Nandi et al., 14 Jan 2025).
• Instrumentation: Optimal excitation is achieved at the E$_{11}$ absorption ($985$ nm for CNTs), with emission collection via $>1064$ nm long-pass filters and noise-mitigated InGaAs detection (Nandi et al., 14 Jan 2025). For nanoscale 3D tracking, engineered point-spread functions (Double-Helix phase masks) yield sub-10 nm localization precision in thick brain tissue (Nandi et al., 14 Jan 2025).

This suggests that ultrabright, ultra-short, photostable NIR-II nano-emitters are positioned to advance deep-tissue bioimaging, fiber communications, and quantum photonic technologies. Key open questions remain regarding quantum yield quantification, site-controlled defect fabrication, charge-state management, and spectrally selective imaging in sub-100 nm particles (Johnson et al., 2024).